Swell Heraclitus have an idea who it is but I don't mind I've learnt from Giz to try ignore the haters literally by placing them on ignore
BNE is a very early stage Bio perhaps too early for most and it suffers from its legacy as being a crap stock with La Jolla funding
A recap was done recently to change all that by the team that recapped AHZ awhile back but the market is still uninterested despite it being a new restructured company with new funding in place
$5m cap and $3m in the bank so priced at next to nothing
ALT is another I'm watching closely for a re-entry as it strikes me as an ISN Mk2 with their PeriCoach incontinence device, its a huge market and even a small fraction of market sales will be a huge company maker we shall see
PAA is also another especially since it has moved from Animal to Human trials for its cancer drug and this could prove to be a big pivotal moment for the company, funding may be an issue but it is cash flow positive with its side business I don't think they are desperate for cash
